You can't get upset with people for selling, sorry
Post# of 148162
I hope they get approval in the United States first. Cytodyn helped my trading account immensely and I truly hope they are a success. I was looking to jump back in, but I'm going to have to wait for the bleeding to stop again. But I'll be brutally honest here, as someone without a current position and is watching to gauge whether or not I should buy back in: The latest PR seems like a desperation move. Couple that with the latest SEC filing, and it's a disaster.
If they can secure some type of non-dilutive funding in the near future, it would go a long way with current shareholders. The other possibility would be uplisting to Nasdaq. This would allow a fresh set of investors to take a closer look, not to mention the current success of Nasdaq would likely translate to Cytodyn as well, thus fueling a strong run back above $9.00.
I could offer another possible scenario that would help the share price a bit, but knowing this community, I will reserve my opinion for fear of reprisal. LoL